Daniela Rotin

Daniela Rotin

Auto-generated profile, based on publicly available information

Daniela Rotin

Cell & Systems Biology Program, The Hospital for Sick Children, Toronto, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2009 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
DRDaniela Rotin
Daniela Rotin
SKSharad Kumar
Sharad Kumar

22 May 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
RMRuth Milkereit
Ruth Milkereit
APAvinash Persaud
Avinash Persaud
LVLiviu Vanoaica
Liviu Vanoaica
AGAdriano Guetg
Adriano Guetg
FVFrançois Verrey
François Verrey
DRDaniela Rotin
Daniela Rotin
Mammalian target of rapamycin 1 (mTORC1), a master regulator of cellular growth, is activated downstream of growth factors, energy signalling and intracellular essential amino acids (EAAs) such as Leu. mTORC1 activation occurs at the lysosomal membrane, and involves V-ATPase stimulation by intra-lysosomal EAA (inside-out activation), leading to activation of the Ragulator, RagA/B-GTP and mTORC1 via Rheb-GTP. How Leu enters the lysosomes is unknown. Here we identified the lysosomal protein LAPTM4b as a binding partner for the Leu transporter, LAT1-4F2hc (SLC7A5-SLAC3A2). We show that LAPTM4b recruits LAT1-4F2hc to lysosomes, leading to uptake of Leu into lysosomes, and is required for mTORC1 activation via V-ATPase following EAA or Leu stimulation. These results demonstrate a functional Leu transporter at the lysosome, and help explain the inside-out lysosomal activation of mTORC1 by Leu/EAA.

1 December 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PPPamela J. Plant
Pamela J. Plant
HYHerman Yeger
Herman Yeger
OSOlivier Staub
Olivier Staub
PHPERRY HOWARD
PERRY HOWARD
DRDaniela Rotin
Daniela Rotin
Neuronal precursor cell-expressed developmentally down-regulated 4 (Nedd4) is a ubiquitin protein ligase (E3) containing a hect domain, 3 or 4 WW domains, and a putative C2 domain. We have recently demonstrated an association between the WW domains of Nedd4 and the proline-rich PY motifs (XPPXY) of the epithelial Na+ channel, as well as with PY motifs of several other proteins. The role of the putative C2 domain of Nedd4 has not been elucidated. Here we show that Nedd4, endogenously expressed in Madin-Darby canine kidney cells, was redistributed from the cytosolic to the particulate fraction in response to ionomycin plus Ca2+ treatment. A similar treatment of polarized Madin-Darby canine kidney cells led to an apical and lateral membrane localization of Nedd4, as determined by immunostaining and confocal microscopy. The C2 domain of Nedd4, expressed as a glutathioneS-transferase (GST) fusion protein, was sufficient to bind cellular membranes in a Ca2+-dependent manner. Moreover, this GST-Nedd4-C2 domain was able to mediate Ca2+-dependent interactions with phosphatidylserine, phosphatidylinositol, and phosphatidylcholine liposomes in vitro. An epitope-tagged Nedd4 lacking its C2 domain and stably expressed in Madin-Darby canine kidney cells failed to mediate the Ca2+-induced plasma membrane localization seen in wild-type (epitope-tagged) Nedd4. These results indicate that the putative C2 domain of Nedd4 acts as a bona fide C2 domain which binds phospholipids and membranes in a Ca2+-dependent fashion and is involved in localizing the protein primarily to the apical region of polarized epithelial cells in response to Ca2+.

24 June 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
FFFatemeh Fouladkou
Fatemeh Fouladkou
TLTamara Landry
Tamara Landry
HKHiroshi Kawabe
Hiroshi Kawabe
ANAntje Neeb
Antje Neeb
CLChen Lu
Chen Lu
DRDaniela Rotin
Daniela Rotin
PTEN is a tumor suppressor frequently mutated in cancer. Recent reports implicated Nedd4-1 as the E3 ubiquitin ligase for PTEN that regulates its stability and nuclear localization. We tested the physiological role of Nedd4-1 as a PTEN regulator by using cells and tissues derived from two independently generated strains of mice with their Nedd4-1 gene disrupted. PTEN stability and ubiquitination were indistinguishable between the wild-type and Nedd4-1-deficient cells, and an interaction between the two proteins could not be detected. Moreover, PTEN subcellular distribution, showing prominent cytoplasmic and nuclear staining, was independent of Nedd4-1 presence. Finally, activation of PKB/Akt, a major downstream target of cytoplasmic PTEN activity, and the ability of PTEN to transactivate the Rad51 promoter, a measure of its nuclear function, were unaffected by the loss of Nedd4-1. Taken together, our results fail to support a role for Nedd4-1 as the E3 ligase regulating PTEN stability and subcellular localization.

5 June 2007 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
RGRonish Gupta
Ronish Gupta
BKBart Kus
Bart Kus
CFChristopher Fladd
Christopher Fladd
JWJames Wasmuth
James Wasmuth
RTRaffi Tonikian
Raffi Tonikian
DRDaniela Rotin
Daniela Rotin
Ubiquitin‐protein ligases (E3s) are responsible for target recognition and regulate stability, localization or function of their substrates. However, the substrates of most E3 enzymes remain unknown. Here, we describe the development of a novel proteomic in vitro ubiquitination screen using a protein microarray platform that can be utilized for the discovery of substrates for E3 ligases on a global scale. Using the yeast E3 Rsp5 as a test system to identify its substrates on a yeast protein microarray that covers most of the yeast ( Saccharomyces cerevisiae ) proteome, we identified numerous known and novel ubiquitinated substrates of this E3 ligase. Our enzymatic approach was complemented by a parallel protein microarray protein interaction study. Examination of the substrates identified in the analysis combined with phage display screening allowed exploration of binding mechanisms and substrate specificity of Rsp5. The development of a platform for global discovery of E3 substrates is invaluable for understanding the cellular pathways in which they participate, and could be utilized for the identification of drug targets. ### Synopsis Post‐translational modification of proteins by the ubiquitin pathway has been implicated in numerous cellular processes. Substrates of this pathway are covalently modified by the attachment of a small protein called ubiquitin and as a result are targeted for degradation, endocytosis, protein sorting or subnuclear trafficking. An enzyme called E3, or ubiquitin ligase, is responsible for the specificity of the reaction, and associates with specific substrates in order to ensure their ubiquitination. Defects in the ability of the E3 to interact with substrates have been implicated in numerous diseases, including neurodegeneration, immunological disorders, hypertension and cancers. A significant fraction of the proteome is regulated by the ubiquitin pathway and eukaryotic genomes express hundreds of E3 enzymes to coordinate the ubiquitination of cellular proteins. Currently, most E3 enzymes have not been linked to any specific substrates despite advances in understanding the mechanics of the ubiquitin system and its role in the cell. We have developed a platform that allows systematic and high‐throughput discovery of ubiquitinated E3 substrates. We expect that this application will be tremendously useful for gaining insights into cellular systems and will likely be exploited by the biomedical industry. In order to develop this platform, we used Rsp5, a yeast E3, as a model system. E3 enzymes from this family have been implicated in numerous cellular functions including protein degradation, endocytosis, sorting and trafficking. For example, Rsp5 regulates mitochondrial inheritance, drug resistance, intracellular pH, fatty acid biosynthesis, protein sorting at the trans‐Golgi network and transcriptional regulation. Nedd4 (or Nedd4‐2), the human Rsp5 homologue, prevents hypertension by ubiquitinating and regulating endocytosis of ENaC in the kidney. Our aim was to identify substrates of Rsp5 in the yeast proteome using the protein microrarray technology as our experimental platform. The arrays used in this study contain purified proteins immobilized at a high spatial density on standard sized slides and contain the majority of yeast proteins ([Figure 1][1]). Therefore, the yeast proteome can be readily exploited using traditional biochemical approaches. Recent studies have employed protein microarrays containing full‐length proteins to discover calmodulin interacting proteins and to probe for a variety of other protein–protein interactions, as well as antibody–antigen, protein–small molecule, protein–lipid and protein–nucleotide associations. Protein microarrays are expected to provide excellent platforms for identifying post‐translational modifications, but to date, only a few studies have assayed an enzymatic activity using this technology. In the current study, we have successfully used yeast ( S. cerevisae ) protein microarrays, covering most of the yeast proteome, to assay the enzymatic (ubiquitination) activity and binding ability of Rsp5 to substrate proteins, and we have identified previously reported and novel ubiquitinated substrates and interacting partners of this E3 ligase. The data generated in this study were integrated with published data from large‐scale physical and genetic interaction studies to generate Rsp5 interaction networks. Our results demonstrate the feasibility of identifying substrates of E3 ligases and possibly other enzymes using a proteome microarray approach, and demonstrate how this approach can yield informative data regarding the binding mechanisms and substrate specificity of an E3 ligase enzyme. Mol Syst Biol. 3: 116 [1]: #F1

1 December 2009 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
APAvinash Persaud
Avinash Persaud
PAPhilipp Alberts
Philipp Alberts
EAEva M Amsen
Eva M Amsen
XXXuejian Xiong
Xuejian Xiong
JWJames Wasmuth
James Wasmuth
DRDaniela Rotin
Daniela Rotin
Target recognition by the ubiquitin system is mediated by E3 ubiquitin ligases. Nedd4 family members are E3 ligases comprised of a C2 domain, 2–4 WW domains that bind PY motifs (L/PPxY) and a ubiquitin ligase HECT domain. The nine Nedd4 family proteins in mammals include two close relatives: Nedd4 (Nedd4‐1) and Nedd4L (Nedd4‐2), but their global substrate recognition or differences in substrate specificity are unknown. We performed in vitro ubiquitylation and binding assays of human Nedd4‐1 and Nedd4‐2, and rat‐Nedd4‐1, using protein microarrays spotted with ∼8200 human proteins. Top hits (substrates) for the ubiquitylation and binding assays mostly contain PY motifs. Although several substrates were recognized by both Nedd4‐1 and Nedd4‐2, others were specific to only one, with several Tyr kinases preferred by Nedd4‐1 and some ion channels by Nedd4‐2; this was subsequently validated in vivo. Accordingly, Nedd4‐1 knockdown or knockout in cells led to sustained signalling via some of its substrate Tyr kinases (e.g. FGFR), suggesting Nedd4‐1 suppresses their signalling. These results demonstrate the feasibility of identifying substrates and deciphering substrate specificity of mammalian E3 ligases.